TABLE 5.
Item | Treatment |
SEM |
P-value |
|||||
CON | RES | LPS | RES + LPS | LPS | RES | LPS × RES | ||
Plasma | ||||||||
GSH-Px (U/mL) | 872.65a | 896.98a | 713.50b | 836.60ab | 69.24 | 0.039* | 0.152 | 0.328 |
SOD (U/mg) | 175.96a | 179.11a | 140.71b | 174.47a | 12.73 | 0.042* | 0.057 | 0.109 |
CAT (U/mL) | 3.37b | 4.23a | 2.57b | 3.15b | 0.40 | 0.004* | 0.021* | 0.632 |
T-AOC (mmol/L) | 0.58b | 0.72a | 0.43c | 0.56b | 0.05 | <0.001* | 0.001* | 0.732 |
MDA (nmol/mL) | 4.46ab | 4.01b | 5.18a | 4.74ab | 0.44 | 0.048* | 0.189 | 0.979 |
Jejunal mucosa | ||||||||
GSH-Px (U/mg prot) | 197.79 | 209.22 | 181.74 | 193.13 | 18.11 | 0.228 | 0.386 | 0.999 |
SOD (U/mg prot) | 29.57ab | 33.84a | 25.20b | 30.64ab | 3.25 | 0.054 | 0.022* | 0.858 |
CAT (U/mg prot) | 1.10 | 1.12 | 0.91 | 0.98 | 0.12 | 0.065 | 0.586 | 0.757 |
T-AOC (mmol/mg prot) | 58.25ab | 69.32a | 46.89b | 59.96ab | 6.54 | 0.040* | 0.019* | 0.832 |
MDA (nmol/mg prot) | 0.70 | 0.62 | 0.78 | 0.72 | 0.062 | 0.076 | 0.154 | 0.892 |
1Values are means and standard error of the means, n = 5 per treatment.
abMeans in the same row with different superscripts differ (P < 0.05).
CON, control; RES, resveratrol; LPS, lipopolysaccharide; RES + LPS, dietary resveratrol treatment followed by LPS challenge; GSH-Px, glutathione peroxidase; SOD, superoxide dismutase; CAT, catalase; T-AOC, total antioxidant capacity; MDA, malondialdehyde.
The * indicates statistically significant difference (P < 0.05).